Marcus Rashford’s deflected strike deep into stoppage time moved Manchester United to within two points of Liverpool at the top of the Premier League with a 1-0 win over Wolves on Tuesday. United laboured for long spells against a youthful Wolves side, but got a huge slice of fortune in the 93rd minute when Rashford’s shot hit Romain Saiss to leave Rui Patricio helpless. Victory takes Ole Gunnar Solskjaer’s men up to second and continues an excellent run of 23 points from the last possible 27 to mount an unlikely title challenge after a slow start to the season. Despite enjoying one more day’s rest amid the packed festive schedule than their opponents, Solskjaer made six changes from the side that drew 2-2 at Leicester on Boxing Day. Edinson Cavani made just his second Premier League start...
Chioma Ubogagu scored her first goal in the 2020-21 Spanish Primera Iberdrola campaign as Real Madrid thrashed Espanyol 8-1 at Ciutat Esportiva Dani Jarque on Sunday. The 28-year-old had starred for the USA at youth level before playing for England at senior level thrice, albeit in friendlies, and still eligible to represent Nigeria due to the new Fifa eligibility rules. Having been handed her second start of the season, the England international put up an impressive display in front of goal as her side extend their winning streak in the Spanish top-flight. Las Blancas made a fantastic start to the encounter as Sofia Jakobsson’s perfect pass allowed Olga Carmona to score the opening goal for the visitors after just nine minutes. In the 33rd minute, Teresa Abelleira set up Ubogagu to double...
A coronavirus vaccine developed by Britain’s University of Oxford and the pharmaceutical firm AstraZeneca has shown successful results in early trials. If it is approved by regulators, the vaccine appears suitable for a fast rollout around the globe. Early analysis of trials involving 20,000 volunteers in Britain and Brazil show the vaccine is at least 62% effective after two doses. In volunteers given a different dosing regimen — a half dose, followed by a full dose — that figure rose to 90%. The average efficacy of the two dosing methods is 70%. None of those given the vaccine developed severe COVID-19 illness. Andrew Pollard, director of the Oxford Vaccine Group, said the recent successful trials of three different vaccines by Oxford-AstraZeneca, Pfizer-BioNTech and Moderna, represent a...